Durvalumab vs Naproxen

Durvalumab vs Naproxen: Overview

This comparison examines the pharmacological differences between Durvalumab and Naproxen.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Naproxen: Non-selective COX inhibitor.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Naproxen — 12-17 hours.

Chemical Properties

Molecular Formula: Naproxen — C14H14O3.

Molecular Weight: Naproxen — 230.2590 g/mol.

Type: Durvalumab — Antibody; Naproxen — Small molecule.